10-Q Filing

RELMADA THERAPEUTICS, INC. CIK: 1553643 Q2 2016

Filing Information

Form Type	10-Q
Accession Number	`0001213900-16-010641`
Period End Date	20151231
Filing Date	20160205
Fiscal Year	2016
Fiscal Period	Q2
XBRL Instance	relm-20151231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 58 Income Statement 44 Cash Flow Statement 58

Balance Sheet 58 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$25.56M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$31.42M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$15.13M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$22.47M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$528.14K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$1.50M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$23.97M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$15.66M	USD	Point-in-time
Fixed assets, net	`PropertyPlantAndEquipmentNet`	$535.74K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Fixed assets, net	`PropertyPlantAndEquipmentNet`	$23.91K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	12.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	10.78M	shares	Point-in-time
Other assets	`OtherAssets`	$412.79K	USD	Point-in-time
Other assets	`OtherAssets`	$400.82K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	12.00M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	10.78M	shares	Point-in-time
Total assets	`Assets`	$16.60M	USD	Point-in-time
Total assets	`Assets`	$24.39M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.69M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$835.28K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$482.27K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.56M	USD	Point-in-time
Note payable	`NotesPayableCurrent`	$88.53K	USD	Point-in-time
Note payable	`NotesPayableCurrent`	$263.75K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$14.00M	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$1.45M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.78M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$15.58M	USD	Point-in-time
Deferred rent liability	`DeferredRentCreditNoncurrent`	$54.83K	USD	Point-in-time
Deferred rent liability	`DeferredRentCreditNoncurrent`	-	USD	Point-in-time
Total liabilities	`Liabilities`	$15.58M	USD	Point-in-time
Total liabilities	`Liabilities`	$4.84M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, value	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, value	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value,100,000,000 shares authorized, 11,999,122 and 10,778,474 shares issued and outstanding, respectively	`CommonStockValue`	$10.78K	USD	Point-in-time
Common stock, $0.001 par value,100,000,000 shares authorized, 11,999,122 and 10,778,474 shares issued and outstanding, respectively	`CommonStockValue`	$12.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$84.92M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$85.67M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-73.92M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-76.12M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$11.76M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$8.81M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$16.60M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$24.39M	USD	Point-in-time

Income Statement 44 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$2.81M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.12M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$4.98M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.09M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.29M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$3.60M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$5.30M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$5.37M	USD	2 Qtrs
Total Operating Expenses	`OperatingExpenses`	$5.72M	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$8.11M	USD	2 Qtrs
Total Operating Expenses	`OperatingExpenses`	$10.35M	USD	2 Qtrs
Total Operating Expenses	`OperatingExpenses`	$4.38M	USD	1 Quarter
Loss from Operations	`OperatingIncomeLoss`	$-4.38M	USD	1 Quarter
Loss from Operations	`OperatingIncomeLoss`	$-5.72M	USD	1 Quarter
Loss from Operations	`OperatingIncomeLoss`	$-10.35M	USD	2 Qtrs
Loss from Operations	`OperatingIncomeLoss`	$-8.11M	USD	2 Qtrs
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$9.84M	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$-16.28M	USD	2 Qtrs
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$12.56M	USD	2 Qtrs
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$3.26M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$1.89K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$5.11K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$7.22K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$843.00	USD	1 Quarter
Interest expense	`InterestExpense`	$1.17K	USD	1 Quarter
Interest expense	`InterestExpense`	$2.81K	USD	2 Qtrs
Interest expense	`InterestExpense`	$1.10K	USD	1 Quarter
Interest expense	`InterestExpense`	$4.37K	USD	2 Qtrs
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$12.55M	USD	2 Qtrs
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$3.26M	USD	1 Quarter
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$-16.28M	USD	2 Qtrs
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$9.84M	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$2.20M	USD	2 Qtrs
Net Income (Loss)	`NetIncomeLoss`	$-2.46M	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$-24.38M	USD	2 Qtrs
Net Income (Loss)	`NetIncomeLoss`	$5.46M	USD	1 Quarter
Net Income (Loss) per common share - basic	`EarningsPerShareBasic`	$0.20	USD	2 Qtrs
Net Income (Loss) per common share - basic	`EarningsPerShareBasic`	$-2.66	USD	2 Qtrs
Net Income (Loss) per common share - basic	`EarningsPerShareBasic`	$-0.22	USD	1 Quarter
Net Income (Loss) per common share - basic	`EarningsPerShareBasic`	$0.55	USD	1 Quarter
Net Income (Loss) per common share - diluted	`EarningsPerShareDiluted`	$-0.22	USD	1 Quarter
Net Income (Loss) per common share - diluted	`EarningsPerShareDiluted`	$-2.66	USD	2 Qtrs
Net Income (Loss) per common share - diluted	`EarningsPerShareDiluted`	$0.19	USD	2 Qtrs
Net Income (Loss) per common share - diluted	`EarningsPerShareDiluted`	$0.40	USD	1 Quarter

Cash Flow Statement 58 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$2.20M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$-2.46M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-24.38M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$5.46M	USD	1 Quarter
Depreciation expense	`Depreciation`	$5.91K	USD	2 Qtrs
Depreciation expense	`Depreciation`	$3.50K	USD	2 Qtrs
Common stock issued for services	`CommonStockIssuedForServices`	$180.87K	USD	2 Qtrs
Common stock issued for services	`CommonStockIssuedForServices`	$999.58K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$571.21K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$356.27K	USD	2 Qtrs
Change in fair value of derivative liabilities	`IncreaseDecreaseInDerivativeLiabilities`	$-12.56M	USD	2 Qtrs
Change in fair value of derivative liabilities	`IncreaseDecreaseInDerivativeLiabilities`	$16.28M	USD	2 Qtrs
Deferred rent liability	`DeferredRentLiability`	$54.83K	USD	2 Qtrs
Deferred rent liability	`DeferredRentLiability`	-	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpensesOther`	$957.81K	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpensesOther`	$-923.87K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$810.80K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$223.86K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$139.66K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$1.08M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-7.31M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-6.69M	USD	2 Qtrs
Purchase of fixed assets	`PaymentsToAcquireProductiveAssets`	$17.17K	USD	2 Qtrs
Purchase of fixed assets	`PaymentsToAcquireProductiveAssets`	$476.11K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-476.11K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-17.17K	USD	2 Qtrs
Net proceeds from the exercise of warrants	`ProceedsFromWarrantExercises`	-	USD	2 Qtrs
Net proceeds from the exercise of warrants	`ProceedsFromWarrantExercises`	$13.43M	USD	2 Qtrs
Principal payments of note payable	`RepaymentsOfNotesPayable`	$175.22K	USD	2 Qtrs
Principal payments of note payable	`RepaymentsOfNotesPayable`	$255.54K	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$13.18M	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-175.22K	USD	2 Qtrs
Net (decrease) increase in cash and cash equivalents	`CashPeriodIncreaseDecrease`	$-7.34M	USD	2 Qtrs
Net (decrease) increase in cash and cash equivalents	`CashPeriodIncreaseDecrease`	$5.85M	USD	2 Qtrs
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$25.56M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$31.42M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$15.13M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$22.47M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$25.56M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$31.42M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$15.13M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$22.47M	USD	Point-in-time
Income taxes	`IncomeTaxesPaid`	-	USD	2 Qtrs
Income taxes	`IncomeTaxesPaid`	-	USD	2 Qtrs
Interest	`InterestPaid`	$2.81K	USD	2 Qtrs
Interest	`InterestPaid`	$4.37K	USD	2 Qtrs
Payable incurred for purchases of fixed assets	`PayableIncurredForPurchasesOfFixedAssets`	$41.63K	USD	2 Qtrs
Payable incurred for purchases of fixed assets	`PayableIncurredForPurchasesOfFixedAssets`	-	USD	2 Qtrs
Issuances of common stock resulting from cashless exercise of warrants	`IssuancesOfCommonStockResultingFromCashlessExerciseOfWarrants`	$1.09K	USD	2 Qtrs
Issuances of common stock resulting from cashless exercise of warrants	`IssuancesOfCommonStockResultingFromCashlessExerciseOfWarrants`	-	USD	2 Qtrs
Conversion of Class A convertible preferred stock to common stock	`ConvertiblePreferredStockToCommonStock`	$2.87K	USD	2 Qtrs
Conversion of Class A convertible preferred stock to common stock	`ConvertiblePreferredStockToCommonStock`	$72.00	USD	2 Qtrs
Financing of insurance premiums by issuance of note payable	`FinancingOfNotePayable`	$263.80K	USD	Point-in-time
Financing of insurance premiums by issuance of note payable	`FinancingOfNotePayable`	$293.62K	USD	2 Qtrs
Cancellation of note payable for insurance premiums	`CancellationOfNotePayableInConnectionWithDirectorAndOfficerPolicy`	$55.22K	USD	2 Qtrs
Cancellation of note payable for insurance premiums	`CancellationOfNotePayableInConnectionWithDirectorAndOfficerPolicy`	-	USD	2 Qtrs
Reclassification of warrant liabilities to additional paid-in capital for warrant exercises	`ReclassificationOfWarrantLiabilitiesToAdditionalPaidInCapitalForWarrantExercises`	-	USD	2 Qtrs
Reclassification of warrant liabilities to additional paid-in capital for warrant exercises	`ReclassificationOfWarrantLiabilitiesToAdditionalPaidInCapitalForWarrantExercises`	$15.30M	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.